Finding the best shock strength for atrial fibrillation treatment
Treatments studied
Part of Heart & circulation clinical trials.
This study compares different shock energy levels to find the most effective and safe way to reset an irregular heartbeat (atrial fibrillation) back to normal rhythm using a procedure called electrical cardioversion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation or a related irregular heartbeat called atypical atrial flutter.
- Your doctor has recommended a procedure to reset your heart rhythm (electrical cardioversion).
- You do not have typical atrial flutter or focal atrial tachycardia (specific types of irregular heartbeats).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special defibrillation technique that uses two shocks to reset the heart's rhythm in people with persistent atrial fibrillation. It aims to help patients regain a normal heartbeat without the need for more invasive procedures.
This trial tests whether a procedure called electrical cardioversion (a controlled shock to reset your heart rhythm) can help explain and possibly improve symptoms of atrial fibrillation and heart failure. If you qualify, you'll receive this procedure and your symptoms will be closely monitored.
This study tests whether doing a short cycling exercise right before a heart shock procedure (called electrical cardioversion) can make the procedure more effective at restoring a normal heartbeat. If successful, it could simplify treatment for people with persistent atrial fibrillation.
This study compares different heart rate targets for people with ongoing atrial fibrillation (an irregular heartbeat) to find which one improves symptoms and quality of life. It may help you and your doctor choose the best treatment plan.
This study compares a newer, faster type of ablation (high-power short-duration) with the standard approach for treating atrial fibrillation. The goal is to see which method is safer and more effective at restoring a normal heart rhythm.
This study tests whether giving the medicine amiodarone before a scheduled electrical cardioversion (a procedure that shocks the heart back into rhythm) improves the chances of restoring a normal heartbeat in people with persistent atrial fibrillation. It compares outcomes with and without this pre-treatment.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.